China National Accord Medicines (SZSE:200028) Cyclically Adjusted Book per Share: HK$14.87 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SZSE:200028 China National Accord Medicines Corp Ltd SZSE:200028
82 GF Score
Price HK$12.01
GF Value HK$13.65
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is China National Accord Medicines Cyclically Adjusted Book per Share?

China National Accord Medicines SZSE:200028 -0.50% 82 Cyclically Adjusted Book per Share is HK$14.87 as of Jun. 2026. GuruFocus rates SZSE:200028 with a GF Score™ of 82/100 and a GF Value™ of HK$13.65 (Modestly Undervalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

China National Accord Medicines's adjusted book value per share for the three months ended in Jun. 2026 was HK$35.659. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is HK$14.87 for the trailing ten years ended in Jun. 2026.

During the past 12 months, China National Accord Medicines's average Cyclically Adjusted Book Growth Rate was 8.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 10.40% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 12.80% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 18.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of China National Accord Medicines was 31.70% per year. The lowest was 10.20% per year. And the median was 19.95% per year.

As of today (2026-09-15), China National Accord Medicines's current stock price is HK$12.01. China National Accord Medicines's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was HK$14.87. China National Accord Medicines's Cyclically Adjusted PB Ratio of today is 0.81.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of China National Accord Medicines was 10.35. The lowest was 0.81. And the median was 1.98.


China National Accord Medicines  (SZSE:200028) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

China National Accord Medicines's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=12.01/14.87
=0.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of China National Accord Medicines was 10.35. The lowest was 0.81. And the median was 1.98.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


China National Accord Medicines Cyclically Adjusted Book per Share Related Terms


China National Accord Medicines Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for China National Accord Medicines's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China National Accord Medicines Cyclically Adjusted Book per Share Chart

China National Accord Medicines Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.11 9.55 8.95 10.39 12.56

China National Accord Medicines Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.33 12.28 12.56 12.39 14.87

SZSE:200028 vs MCK, COR, CAH: Cyclically Adjusted Book per Share Comparison

For the Medical Distribution subindustry, China National Accord Medicines's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China National Accord Medicines Cyclically Adjusted PB Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, China National Accord Medicines's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where China National Accord Medicines's Cyclically Adjusted PB Ratio falls into.


SZSE:200028
82GF Score
China National Accord Medicines Corp Ltd SZSE:200028
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China National Accord Medicines Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, China National Accord Medicines's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=35.659/116.0564*116.0564
=35.659

Current CPI (Jun. 2026) = 116.0564.

China National Accord Medicines Quarterly Data

Book Value per Share CPI Adj_Book
201609 13.606 102.400 15.421
201612 18.275 102.600 20.672
201703 16.049 103.200 18.048
201706 16.589 103.100 18.674
201709 17.696 104.100 19.728
201712 18.187 104.500 20.198
201803 19.644 105.300 21.651
201806 19.648 104.900 21.738
201809 20.570 106.600 22.395
201812 21.557 106.500 23.491
201903 22.766 107.700 24.532
201906 22.499 107.700 24.245
201909 22.401 109.800 23.677
201912 23.467 111.200 24.492
202003 23.599 112.300 24.388
202006 23.596 110.400 24.805
202009 25.193 111.700 26.176
202012 27.008 111.500 28.112
202103 27.812 112.662 28.650
202106 28.309 111.769 29.395
202109 28.896 112.215 29.885
202112 29.850 113.108 30.628
202203 30.566 114.335 31.026
202206 29.375 114.558 29.759
202209 28.705 115.339 28.884
202212 29.414 115.116 29.654
202303 30.675 115.116 30.926
202306 29.681 114.558 30.069
202309 29.739 115.339 29.924
202312 31.113 114.781 31.459
202403 31.590 115.227 31.817
202406 31.264 114.781 31.611
202409 32.555 115.785 32.631
202412 30.814 114.893 31.126
202503 31.520 115.116 31.778
202506 32.380 114.907 32.704
202509 32.898 115.471 33.065
202512 33.581 115.832 33.646
202603 35.466 116.303 35.391
202606 35.659 116.056 35.659

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of HK$14.87 mean?
China National Accord Medicines (SZSE:200028) has a Cyclically Adjusted Book per Share of HK$14.87 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on China National Accord Medicines and its competitors.
Is China National Accord Medicines' Cyclically Adjusted Book per Share too high?
China National Accord Medicines' current Cyclically Adjusted Book per Share is HK$14.87. Overall, China National Accord Medicines has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does China National Accord Medicines' Cyclically Adjusted Book per Share compare to MCK and COR?
China National Accord Medicines' Cyclically Adjusted Book per Share of HK$14.87 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Distribution company?
A good Cyclically Adjusted Book per Share depends on the Medical Distribution industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on China National Accord Medicines and its competitors. China National Accord Medicines's current Cyclically Adjusted Book per Share is HK$14.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China National Accord Medicines stock overvalued right now?
Based on GuruFocus' analysis, China National Accord Medicines (SZSE:200028) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$13.65, compared to a current price of HK$12.01 — trading 12% below its estimated fair value. The current Cyclically Adjusted Book per Share is HK$14.87. China National Accord Medicines' overall GF Score™ is 82/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For China National Accord Medicines (SZSE:200028), the current Cyclically Adjusted Book per Share is HK$14.87 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China National Accord Medicines (SZSE:200028) Overvalued in 2026?

Based on GuruFocus' analysis, China National Accord Medicines stock appears to be undervalued. The current stock price of HK$12.01 is trading 12% below its estimated GF Value™ of HK$13.65. GuruFocus considers China National Accord Medicines to be Modestly Undervalued.

Key valuation signals for SZSE:200028:

  • Cyclically Adjusted Book per Share: HK$14.87
  • GF Value™: HK$13.65 vs. price of HK$12.01 (12% below fair value)
  • GF Score™: 82/100 with 6 warning signs

No single metric tells the full story. See the SZSE:200028 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


China National Accord Medicines Business Description

Other Exchanges 000028:China
Address No. 15, Ba Gua Si 4th Road, Accord Pharmaceutical Building, Futian District, Guangdong Province, Shenzhen, CHN, 518029
China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.
82GF Score

Get the complete analysis for SZSE:200028

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$12.01
Price
HK$13.65
GF Value